Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab plus Ipilimumab in Classical Kaposi Sarcoma
NCT03219671Phase 2Unknown
- Start
- Apr 2018
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, ipilimumab in Classical Kaposi Sarcoma. Status: unknown.
02
Drugs
nivolumabipilimumab
03
Conditions
Classical Kaposi Sarcoma
Beyond the preview
Go deeper on NCT03219671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219671.